EVALUATION OF A NEW CHEMOTHERAPEUTIC AGENT IN PATIENTS WITH ADVANCED REFRACTORY ACUTE LEUKEMIA - STUDIES OF 6-AZAURACIL

被引：20

作者：

FREIREICH, EJ

FREI, E

HOLLAND, JF

PINKEL, D

SELAWRY, O

ROTHBERG, H

HAURANI, F

TAYLOR, R

GEHAN, EA

机构：

来源：

BLOOD | 1960年 / 16卷 / 03期

关键词：

D O I：

10.1182/blood.V16.3.1268.1268

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1268 / 1278

页数：11

共 9 条

[1]

BISEL HF, 1956, BLOOD, V11, P676

[2]

DIXON WJ, 1957, INTRO STAT ANAL, P292

[3] A COMPARATIVE STUDY OF 2 REGIMENS OF COMBINATION CHEMOTHERAPY IN ACUTE LEUKEMIA [J].

FREI, E ;

HOLLAND, JF ;

SCHNEIDERMAN, MA ;

PINKEL, D ;

SELKIRK, G ;

FREIREICH, EJ ;

SILVER, RT ;

GOLD, GL ;

REGELSON, W .

BLOOD, 1958, 13 (12) :1126-1148

[4]

HAKALA MT, 1956, P AM ASSOC CANC RES, V2, P113

[5]

JAFFE JULIAN J., 1957, YALE JOUR BIOL AND MED, V30, P168

[6]

SHNIDER BI, 1960, CANCER RES, V20, P28

[7]

Siegel S., 1956, NONPARAMETRIC STAT, P127

[8] THE ANTICANCEROUS ACTION OF 6-AZAURACIL(3,5-DIOXO-2,3,4,5-TETRAHYDRO-1,2,4-TRIAZINE) [J].

SORM, F ;

JAKUBOVIC, A ;

SLECHTA, L .

EXPERIENTIA, 1956, 12 (07) :271-272

[9]

Welch AD, 1957, P AM ASSOC CANC RES, V2, P259

← 1 →